832
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Why is pituitary carcinoma so rare?

, &
Pages 1-3 | Received 17 Nov 2022, Accepted 09 Jan 2023, Published online: 16 Jan 2023

References

  • Molitch ME. Diagnosis and treatment of pituitary adenomas: a Review. JAMA. 2017;317(5):516–524.
  • Todeschini AB, Beer-Furlan A, Montaser AS, et al. Pituitary carcinomas: review of the literature and report of an atypical case. Br J Neurosurg. 2020;34(5):528–533.
  • Honegger J, Bornemann A, Hoger M, et al. Pituitary carcinoma with malignant growth from first presentation and fulminant clinical course—case report and review of the literature. J Clin Endocrinol Metab. 2011;96(9):2665–2669.
  • Heaney AP. Pituitary carcinoma: difficult diagnosis and treatment. J Clin Endocrinol Metab. 2011;96(12):3649–3660.
  • Yoo F, Kuan EC, Heaney AP, et al. Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review. Pituitary. 2018;21(3):290–301.
  • Trouillas J, Jaffrain-Rea ML, Vasiljkevic A, et al. Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinicians’ questions. Rev Endocrinol Metab Disord. 2020;21(2)243.
  • McCormack A, Bwekkers O, Petersenn S, et al. Treatment of aggressive pituitary tumors and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. Eur J Endocrinol. 2018;178(3):265–276.
  • Melmed S, Kaiser UB, Lopes BB, et al. Clinical biology of the pituitary adenoma. Endocr Rev. 2022;43(6):1003–1037.
  • Hanahan D, Weinberg R. Hallmarks of cancer. Cell. 2000;100(1):57–70.
  • Hanahan D, Weinberg R. Hallmarks of Cancer: the next generation. Cell. 2011;144(5):646–674.
  • Hanahan D. Hallmarks of Cancer: new dimensions. Cancer Discov. 2022;12(1):31–46.
  • Ahmed-Fouad Y, Aanei C. Revisiting the hallmarks of cancer. Am J Cancer Res. 2017;7(5):1016–1036.
  • Andonegui-Elguera S, Silva-Román G, Peña-Martínez E, et al. The genomic landscape of corticotroph tumors: from silent adenomas to ACTH-secreting carcinoma. Int J Mol Sci. 2022;23(9):4861.
  • Mooi WJ. Oncogene-induce cellular senescence: causal factor in the growth arrest of pituitary microadenomas? Horm Res. 2009;71(suppl 2):78–81.
  • Mantovani G, Giardino E, Treppiedi D, et al. Stem cells in pituitary tumors: experimental evidence supporting their existence and their role in tumor clinical behavior. Front Endocrinol. 2019;10:745.
  • Liu XL, Ding J, Meng LH. Oncogene-induced senescence: a double edged sword in cancer. Acta Pharmacol Sin. 2018;39:1553–1558.
  • Alexsandraki K, Khan MM, Chahal HS, et al. Oncogene-induced senescence in pituitary adenomas and carcinomas. Hormones (Athens). 2012;11(3):297–307.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.